BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 8789802)

  • 1. Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host.
    Poller W; Schneider-Rasp S; Liebert U; Merklein F; Thalheimer P; Haack A; Schwaab R; Schmitt C; Brackmann HH
    Gene Ther; 1996 Jun; 3(6):521-30. PubMed ID: 8789802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX.
    Fields PA; Kowalczyk DW; Arruda VR; Armstrong E; McCleland ML; Hagstrom JN; Pasi KJ; Ertl HC; Herzog RW; High KA
    Mol Ther; 2000 Mar; 1(3):225-35. PubMed ID: 10933938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous administration of an E1/E3-deleted adenoviral vector induces tolerance to factor IX in C57BL/6 mice.
    Fields PA; Armstrong E; Hagstrom JN; Arruda VR; Murphy ML; Farrell JP; High KA; Herzog RW
    Gene Ther; 2001 Mar; 8(5):354-61. PubMed ID: 11313811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
    Ji L; Bouvet M; Price RE; Roth JA; Fang B
    Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors.
    Lee JM; Mahtabifard A; Yamada R; Crystal RG; Korst RJ
    Clin Cancer Res; 2002 Nov; 8(11):3561-9. PubMed ID: 12429647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated administration of adenoviral vectors in lungs of human CD4 transgenic mice treated with a nondepleting CD4 antibody.
    Chirmule N; Truneh A; Haecker SE; Tazelaar J; Gao Gp; Raper SE; Hughes JV; Wilson JM
    J Immunol; 1999 Jul; 163(1):448-55. PubMed ID: 10384148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII.
    Andrews JL; Kadan MJ; Gorziglia MI; Kaleko M; Connelly S
    Mol Ther; 2001 Mar; 3(3):329-36. PubMed ID: 11273775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolongation of adenoviral transgene expression in mouse liver by T lymphocyte subset depletion.
    DeMatteo RP; Markmann JF; Kozarsky KF; Barker CF; Raper SE
    Gene Ther; 1996 Jan; 3(1):4-12. PubMed ID: 8929906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterologous expression of adenovirus E3-gp19K in an E1a-deleted adenovirus vector inhibits MHC I expression in vitro, but does not prolong transgene expression in vivo.
    Schowalter DB; Tubb JC; Liu M; Wilson CB; Kay MA
    Gene Ther; 1997 Apr; 4(4):351-60. PubMed ID: 9176522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient depletion of CD4 lymphocyte improves efficacy of repeated administration of recombinant adenovirus in the ornithine transcarbamylase deficient sparse fur mouse.
    Ye X; Robinson MB; Pabin C; Batshaw ML; Wilson JM
    Gene Ther; 2000 Oct; 7(20):1761-7. PubMed ID: 11083498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoviral gene delivery elicits distinct pulmonary-associated T helper cell responses to the vector and to its transgene.
    van Ginkel FW; McGhee JR; Liu C; Simecka JW; Yamamoto M; Frizzell RA; Sorscher EJ; Kiyono H; Pascual DW
    J Immunol; 1997 Jul; 159(2):685-93. PubMed ID: 9218583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector.
    Van Linthout S; Lusky M; Collen D; De Geest B
    Gene Ther; 2002 Nov; 9(22):1520-8. PubMed ID: 12407424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of macrophage depletion and anti-CD40 ligand on transgene expression and redosing with recombinant adenovirus.
    Stein CS; Pemberton JL; van Rooijen N; Davidson BL
    Gene Ther; 1998 Apr; 5(4):431-9. PubMed ID: 9614566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The constitutive expression of the immunomodulatory gp19k protein in E1-, E3- adenoviral vectors strongly reduces the host cytotoxic T cell response against the vector.
    Lee MG; Abina MA; Haddada H; Perricaudet M
    Gene Ther; 1995 Jun; 2(4):256-62. PubMed ID: 7552985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenoviral gene transfer into the normal and injured spinal cord: enhanced transgene stability by combined administration of temperature-sensitive virus and transient immune blockade.
    Romero MI; Smith GM
    Gene Ther; 1998 Dec; 5(12):1612-21. PubMed ID: 10023440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of vaccinia virus-expressed adenovirus E3-19K glycoprotein with class I MHC and its effects on virulence in a murine pneumonia model.
    Grunhaus A; Cho S; Horwitz MS
    Virology; 1994 May; 200(2):535-46. PubMed ID: 8178441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression.
    Michou AI; Santoro L; Christ M; Julliard V; Pavirani A; Mehtali M
    Gene Ther; 1997 May; 4(5):473-82. PubMed ID: 9274725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early region 3-replacement adenovirus recombinants are less pathogenic in cotton rats and mice than early region 3-deleted viruses.
    Berencsi K; Uri A; Valyi-Nagy T; Valyi-Nagy I; Meignier B; Peretz FV; Rando RF; Plotkin SA; Gönczöl E
    Lab Invest; 1994 Sep; 71(3):350-8. PubMed ID: 7933985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNFalpha and IFNgamma induced by innate anti-adenoviral immune responses inhibit adenovirus-mediated transgene expression.
    Sung RS; Qin L; Bromberg JS
    Mol Ther; 2001 May; 3(5 Pt 1):757-67. PubMed ID: 11356080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.